Patent · US Active

Engineered transaminase polypeptides for industrial biocatalysis

US12371678B2 · kind B2 · utility

0Cited by
19References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 19, 2021
Grant dateJul 29, 2025
Priority date
Expiry dateFeb 1, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y206/01
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure provides engineered transaminase polypeptides useful for the synthesis of chiral amine compounds under industrially relevant conditions. The disclosure also provides polynucleotides encoding the engineered transaminase polypeptides, host cells capable of expressing the engineered transaminases, and methods of using the engineered transaminases for the production of chiral amine compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.